ResearchExamining Cost Differences in Malignant Brain and Central Nervous System Tumor Treatment Across US Military Health System Care Settings
ResearchCerebral microbleeds and cavernomas after radiotherapy for brain tumors: a literature review and illustrative cases
ResearchThe relationship between asthma and glioma: a case-control study in a universal access healthcare system
ResearchCTNI-27. PHASE I/II STUDY OF ZOTIRACICLIB FOR RECURRENT MALIGNANT GLIOMAS WITH IDH MUTATIONS: RESULTS OF THE PHASE I STUDY
ResearchBringing the AAN Neuro-oncology Curriculum to Neurology Residency Programs Through Televideo: A Pilot Study Through the AAN Neuro-oncology Section To Develop and Implement a Neurooncology Curriculum Applicable and Accessible to All Adult Neurology Re
ResearchComparative Analysis of Treatment Patterns in DoD Beneficiaries With Malignant Central Nervous System Tumors: A Focus on Care Setting
ResearchA review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon
ResearchUnexplained cerebral hemiatrophy in a case of astrocytoma, IDH-Mutant, WHO grade 3: a case report and literature review
ResearchPromising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review
ResearchVirtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors
ResearchThe COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations
ResearchFeasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial